News Briefing channel feed – Endpoints News

News Briefing channel feed

FDA takes a pass on pegvaliase panel; Flexion terminates an old AstraZeneca pact

8 years ago

AstraZeneca auctions off more assets in $766M deal, reports positive data for Farxiga

8 years ago

Martin Shkreli suddenly changes his tune on Clinton threat; Genenta adds $8M for gene therapy R&D

8 years ago

Another senior AstraZeneca exec jumps ship; Aldeyra shares soar on positive mid-stage data

8 years ago

Summit wins $62M BARDA contract, shares surge; Novartis adds new CGRP data

8 years ago

Kura shares soar on positive PhII cancer data; M&A buzz revolves back to AstraZeneca

8 years ago

Bristol-Myers' checkpoint combo scores in PhIII study; AstraZeneca hands Circassia positive data for COPD drug; Woodford apologizes again

8 years ago

Bioverativ climbs on board Bicycle's peptide platform in discovery deal; Ironwood CFO jumps ship, joins Vertex

8 years ago

Cancer vax biotech Amal grabs $10M round; Global Blood Therapeutics eyes PRV with new FDA designation

8 years ago

Doctors Without Borders say FDA's PRV incentive is misused; Teva drug wins FDA OK on tardive dyskinesia

8 years ago

UK government backs $189M effort to bolster life sci; Bayer files hemophilia drug; Akcea files volanesorsen NDA

8 years ago

Ionis earns $40M on Spinraza advance; Five Prime axes Inhibrx deal

8 years ago

Daiichi Sankyo gets a “breakthrough” at the FDA; InVivo restructures, cuts jobs

8 years ago

Bayer, J&J eye blockbuster supplemental OK for Xarelto; SetPoint raises $30M for bioelectronics

8 years ago

Novartis’ Kisqali to go head-to-head with Pfizer’s Ibrance; USC joins regional biotech alliance

8 years ago

Troubled ImmunoCellular slashes costs, jobs in restructuring; Accelerated Pharma dumps struggling IPO effort

8 years ago

Amgen backs a fresh raise for AI player GNS Healthcare; SQZ names Agarwal as new CMO

8 years ago

Indivior opens up a $30M R&D center; Lilly strikes discovery deal with Topas

8 years ago

Shire CFO to jump ship; Akari taps Zealand vet as new CEO

8 years ago

Medivir out-licenses hep C drug to China’s Ascletis; Cellectis launches pioneering UCART123 US study

8 years ago

BlueRock expands Toronto ops; Unity brings B round to $151M; Novartis backs Altimmune's $15M raise

8 years ago

Takeda inks discovery pact with Stanford; Jounce taps Ariad vet Cole as new CBO

8 years ago

Biosims making slow progress battling blockbusters for market share; FibroGen raising $300M

8 years ago

Cel-Sci shares jump after FDA lifts hold; New upstart is looking for Euro marketing pacts with biotech

8 years ago

First page Previous page 66 67 686970 71 72 Next page Last page